OTC

Popular nasal decongestant doesn't actually relieve congestion, U.S. FDA experts say
The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient.
Acne bacteria trigger cells to produce fats, oils and other lipids essential to skin health: new research
To determine the role that bacteria play in lipid production, we exposed keratinocytes, the cells that make up the epidermis, to different bacteria naturally present on the skin and analyzed changes in lipid composition.

Cytisinicline shows promise for smoking cessation in large U.S. study

The plant molecule has been approved by Health Canada since 2017 and is sold as a natural health product.
Plants of the boreal forest: using traditional Indigenous medicine to create modern treatments

Ancestral knowledge has resulted in some molecules isolated from plants becoming major therapeutic agents in modern medicine, and there is likely much more to come
Shortage of diabetes and weight loss drug Ozempic expected in Canada: manufacturer

Health Canada says intermittent shortages are expected from late August to early October.
Common arthritis drug could boost effectiveness of morning after pill, study finds

Levonorgestrel, often called Plan B, is the most widely available type of emergency contraception. It works by preventing or delaying ovulation.
$1.4B deal: Ozempic manufacturer to acquire Canadian developer of new obesity drug

At the heart of Novo Nordisk’s acquisition of Montreal-based Inversago Pharma is an oral agonist designed to block the receptor protein CB1, which plays an important role in metabolism and appetite regulation.
Supreme Court blocks, for now, OxyContin maker bankruptcy deal that would shield Sacklers

The deal would allow the company to emerge from bankruptcy as a different entity, with its profits used to fight the opioid epidemic. Members of the Sackler family would contribute up to $6 billion.
Health Canada is reviewing two Omicron XBB.1.5-based COVID-19 vaccines

XBB.1.5-based monovalent vaccines from Pfizer and Moderna are undergoing expedited review by Health Canada.
U.K. researchers discover how to make pharmaceuticals from pine trees instead of crude oil

‘Bio-refinery’ model could replace the need to use crude oil to make pharmaceuticals, researchers say.

Popular nasal decongestant doesn't actually relieve congestion, U.S. FDA experts say

Acne bacteria trigger cells to produce fats, oils and other lipids essential to skin health: new research

Cytisinicline shows promise for smoking cessation in large U.S. study

Plants of the boreal forest: using traditional Indigenous medicine to create modern treatments

Shortage of diabetes and weight loss drug Ozempic expected in Canada: manufacturer

Common arthritis drug could boost effectiveness of morning after pill, study finds

$1.4B deal: Ozempic manufacturer to acquire Canadian developer of new obesity drug

Supreme Court blocks, for now, OxyContin maker bankruptcy deal that would shield Sacklers

Health Canada is reviewing two Omicron XBB.1.5-based COVID-19 vaccines

U.K. researchers discover how to make pharmaceuticals from pine trees instead of crude oil